This activity is expired and is no longer available for CME credit.


Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

Author(s)/Faculty: Mario Sznol, MD; Omid Hamid, MD
Release Date: 1/12/2016Expiration Date: 1/11/2017
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this disease has been revolutionized with the development of novel and effective immunotherapeutic and targeted therapies, several of which have received FDA approval. Given this continuously evolving scenario surrounding the management of melanoma, it is critical for clinicians to fully understand the safety and efficacy of novel and emerging therapies, as well as their appropriate utilization in the clinical setting, to optimize patients’ outcomes.

This CME activity addresses recent clinical trial data on novel and emerging agents for the management of metastatic melanoma, as well as approaches for the frontline treatment of this disease.